Europese Unie -
Maltees -
EMA (European Medicines Agency)
actraphane
novo nordisk a/s - insulin human - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus.
Europese Unie -
Maltees -
EMA (European Medicines Agency)
insulatard
novo nordisk a/s - insulin human - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus.
Europese Unie -
Maltees -
EMA (European Medicines Agency)
mixtard
novo nordisk a/s - insulin human - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus.
Europese Unie -
Maltees -
EMA (European Medicines Agency)
protaphane
novo nordisk a/s - insulin human - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus.
Europese Unie -
Maltees -
EMA (European Medicines Agency)
samsca
otsuka pharmaceutical netherlands b.v. - tolvaptan - sindromu adh inappropriate - id-dijuretiċi, - trattament ta 'pazjenti adulti b'iponatrija sekondarja għal sindromu ta' sekrezzjoni mhux xierqa ta 'l-ormon antidijuretiku (siadh).
Europese Unie -
Maltees -
EMA (European Medicines Agency)
efmody
diurnal europe b.v. - hydrocortisone - adrenal hyperplasia, congenital - kortikosterojdi għal użu sistemiku - treatment of congenital adrenal hyperplasia (cah) in adolescents aged 12 years and over and adults.
Europese Unie -
Maltees -
EMA (European Medicines Agency)
copalia
novartis europharm limited - valsartan, amlodipine (as amlodipine besilate) - pressjoni għolja - aġenti li jaġixxu fuq is-sistema renin-angiotensin - trattament ta 'ipertensjoni essenzjali. copalia huwa indikat f'pazjenti li l-pressjoni tad-demm mhijiex ikkontrollata adegwatament bl-amlodipina jew valsartan monoterapija.
Europese Unie -
Maltees -
EMA (European Medicines Agency)
dafiro
novartis europharm limited - l-amlodipina, valsartan - pressjoni għolja - aġenti li jaġixxu fuq is-sistema renin-angiotensin - trattament ta 'ipertensjoni essenzjali. dafiro huwa indikat f'pazjenti li l-pressjoni tad-demm mhijiex ikkontrollata adegwatament bl-amlodipina jew valsartan monoterapija.
Europese Unie -
Maltees -
EMA (European Medicines Agency)
exforge
novartis europharm limited - valsartan, amlodipine (as amlodipine besilate) - pressjoni għolja - aġenti li jaġixxu fuq is-sistema renin-angiotensin - trattament ta 'ipertensjoni essenzjali. exforge huwa indikat f'pazjenti li l-pressjoni tad-demm mhijiex ikkontrollata adegwatament bl-amlodipina jew valsartan monoterapija.
Europese Unie -
Maltees -
EMA (European Medicines Agency)
plenadren
takeda pharmaceuticals international ag ireland branch - hydrocortisone - insuffiċjenza adrenali - kortikosterojdi għal użu sistemiku - trattament ta 'insuffiċjenza adrenali fl-adulti.